nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Topoisomerase Inhibitors—Etoposide—brain cancer	0.56	1	CiPCiCtD
Daunorubicin—XDH—Procarbazine—brain cancer	0.0777	0.236	CbGbCtD
Daunorubicin—TOP2B—Etoposide—brain cancer	0.067	0.203	CbGbCtD
Daunorubicin—CYP1B1—Procarbazine—brain cancer	0.0517	0.157	CbGbCtD
Daunorubicin—ABCC6—Etoposide—brain cancer	0.0256	0.0776	CbGbCtD
Daunorubicin—ABCC10—Etoposide—brain cancer	0.0195	0.0593	CbGbCtD
Daunorubicin—XDH—Carboplatin—brain cancer	0.019	0.0577	CbGbCtD
Daunorubicin—TOP2A—Etoposide—brain cancer	0.0136	0.0413	CbGbCtD
Daunorubicin—ABCC1—Etoposide—brain cancer	0.00754	0.0229	CbGbCtD
Daunorubicin—CYP1A2—Carmustine—brain cancer	0.00702	0.0213	CbGbCtD
Daunorubicin—ABCC2—Carboplatin—brain cancer	0.00665	0.0202	CbGbCtD
Daunorubicin—ABCG2—Carboplatin—brain cancer	0.00601	0.0182	CbGbCtD
Daunorubicin—ABCC2—Etoposide—brain cancer	0.00558	0.0169	CbGbCtD
Daunorubicin—CYP3A4—Temozolomide—brain cancer	0.00531	0.0161	CbGbCtD
Daunorubicin—ABCG2—Etoposide—brain cancer	0.00505	0.0153	CbGbCtD
Daunorubicin—CYP3A4—Lomustine—brain cancer	0.00451	0.0137	CbGbCtD
Daunorubicin—CYP3A5—Etoposide—brain cancer	0.0028	0.00848	CbGbCtD
Daunorubicin—CYP1A2—Etoposide—brain cancer	0.00208	0.00631	CbGbCtD
Daunorubicin—ABCB1—Etoposide—brain cancer	0.00182	0.00552	CbGbCtD
Daunorubicin—NR5A1—hindbrain—brain cancer	0.00119	0.0613	CbGeAlD
Daunorubicin—CYP3A4—Etoposide—brain cancer	0.00109	0.00331	CbGbCtD
Daunorubicin—Idarubicin—CYP2C9—brain cancer	0.000938	1	CrCbGaD
Daunorubicin—TOP2B—hindbrain—brain cancer	0.000758	0.039	CbGeAlD
Daunorubicin—TOP2B—Teniposide—Etoposide—brain cancer	0.000696	0.452	CbGdCrCtD
Daunorubicin—NR5A1—brainstem—brain cancer	0.000683	0.0351	CbGeAlD
Daunorubicin—ABCC6—Podofilox—Etoposide—brain cancer	0.00062	0.402	CbGdCrCtD
Daunorubicin—NR5A1—gonad—brain cancer	0.000506	0.026	CbGeAlD
Daunorubicin—NR5A1—pituitary gland—brain cancer	0.000493	0.0254	CbGeAlD
Daunorubicin—TOP2B—brainstem—brain cancer	0.000435	0.0224	CbGeAlD
Daunorubicin—YWHAG—telencephalon—brain cancer	0.0004	0.0206	CbGeAlD
Daunorubicin—TOP2B—telencephalon—brain cancer	0.000386	0.0198	CbGeAlD
Daunorubicin—NR5A1—endocrine gland—brain cancer	0.000382	0.0197	CbGeAlD
Daunorubicin—NR5A1—head—brain cancer	0.000377	0.0194	CbGeAlD
Daunorubicin—NR5A1—central nervous system—brain cancer	0.000344	0.0177	CbGeAlD
Daunorubicin—NR5A1—cerebellum—brain cancer	0.000337	0.0173	CbGeAlD
Daunorubicin—YWHAG—gonad—brain cancer	0.000334	0.0172	CbGeAlD
Daunorubicin—YWHAG—pituitary gland—brain cancer	0.000326	0.0168	CbGeAlD
Daunorubicin—TOP2B—gonad—brain cancer	0.000322	0.0166	CbGeAlD
Daunorubicin—YWHAG—medulla oblongata—brain cancer	0.000315	0.0162	CbGeAlD
Daunorubicin—TOP2B—pituitary gland—brain cancer	0.000314	0.0162	CbGeAlD
Daunorubicin—TOP2B—medulla oblongata—brain cancer	0.000303	0.0156	CbGeAlD
Daunorubicin—YWHAG—midbrain—brain cancer	0.000287	0.0148	CbGeAlD
Daunorubicin—YWHAG—spinal cord—brain cancer	0.00028	0.0144	CbGeAlD
Daunorubicin—TOP2B—midbrain—brain cancer	0.000277	0.0142	CbGeAlD
Daunorubicin—NR5A1—brain—brain cancer	0.000273	0.0141	CbGeAlD
Daunorubicin—TOP2B—spinal cord—brain cancer	0.00027	0.0139	CbGeAlD
Daunorubicin—ABCC6—endocrine gland—brain cancer	0.000268	0.0138	CbGeAlD
Daunorubicin—ABCC6—head—brain cancer	0.000265	0.0136	CbGeAlD
Daunorubicin—YWHAG—endocrine gland—brain cancer	0.000252	0.013	CbGeAlD
Daunorubicin—YWHAG—head—brain cancer	0.000249	0.0128	CbGeAlD
Daunorubicin—POR—pituitary gland—brain cancer	0.000248	0.0127	CbGeAlD
Daunorubicin—XDH—endocrine gland—brain cancer	0.000246	0.0127	CbGeAlD
Daunorubicin—TOP2B—endocrine gland—brain cancer	0.000243	0.0125	CbGeAlD
Daunorubicin—ABCC10—telencephalon—brain cancer	0.000241	0.0124	CbGeAlD
Daunorubicin—ABCB11—endocrine gland—brain cancer	0.000241	0.0124	CbGeAlD
Daunorubicin—TOP2B—head—brain cancer	0.00024	0.0124	CbGeAlD
Daunorubicin—POR—medulla oblongata—brain cancer	0.000239	0.0123	CbGeAlD
Daunorubicin—YWHAG—central nervous system—brain cancer	0.000228	0.0117	CbGeAlD
Daunorubicin—YWHAG—cerebellum—brain cancer	0.000222	0.0114	CbGeAlD
Daunorubicin—TOP2B—central nervous system—brain cancer	0.000219	0.0113	CbGeAlD
Daunorubicin—POR—midbrain—brain cancer	0.000219	0.0112	CbGeAlD
Daunorubicin—TOP2B—cerebellum—brain cancer	0.000214	0.011	CbGeAlD
Daunorubicin—POR—spinal cord—brain cancer	0.000213	0.011	CbGeAlD
Daunorubicin—ABCC10—gonad—brain cancer	0.000202	0.0104	CbGeAlD
Daunorubicin—ABCC10—pituitary gland—brain cancer	0.000197	0.0101	CbGeAlD
Daunorubicin—POR—endocrine gland—brain cancer	0.000192	0.00987	CbGeAlD
Daunorubicin—CYP1B1—telencephalon—brain cancer	0.00019	0.00976	CbGeAlD
Daunorubicin—ABCC10—medulla oblongata—brain cancer	0.00019	0.00976	CbGeAlD
Daunorubicin—YWHAG—brain—brain cancer	0.000181	0.00929	CbGeAlD
Daunorubicin—TOP2B—brain—brain cancer	0.000174	0.00895	CbGeAlD
Daunorubicin—ABCC10—midbrain—brain cancer	0.000173	0.00892	CbGeAlD
Daunorubicin—ABCC1—telencephalon—brain cancer	0.000171	0.00878	CbGeAlD
Daunorubicin—ABCC10—spinal cord—brain cancer	0.000169	0.0087	CbGeAlD
Daunorubicin—POR—cerebellum—brain cancer	0.000169	0.00869	CbGeAlD
Daunorubicin—CYP1B1—gonad—brain cancer	0.000158	0.00815	CbGeAlD
Daunorubicin—CYP1B1—pituitary gland—brain cancer	0.000155	0.00795	CbGeAlD
Daunorubicin—ABCC10—endocrine gland—brain cancer	0.000152	0.00783	CbGeAlD
Daunorubicin—Stomatitis—Hydroxyurea—brain cancer	0.000145	0.00243	CcSEcCtD
Daunorubicin—ABCB1—blood vessel—brain cancer	0.000144	0.00739	CbGeAlD
Daunorubicin—Mood swings—Temozolomide—brain cancer	0.000143	0.00239	CcSEcCtD
Daunorubicin—Ataxia—Temozolomide—brain cancer	0.000142	0.00237	CcSEcCtD
Daunorubicin—ABCG2—telencephalon—brain cancer	0.000141	0.00727	CbGeAlD
Daunorubicin—Tremor—Procarbazine—brain cancer	0.000141	0.00235	CcSEcCtD
Daunorubicin—Dehydration—Temozolomide—brain cancer	0.000141	0.00235	CcSEcCtD
Daunorubicin—Anaemia—Procarbazine—brain cancer	0.000139	0.00232	CcSEcCtD
Daunorubicin—ABCC1—pituitary gland—brain cancer	0.000139	0.00715	CbGeAlD
Daunorubicin—Dry skin—Temozolomide—brain cancer	0.000139	0.00231	CcSEcCtD
Daunorubicin—POR—brain—brain cancer	0.000137	0.00706	CbGeAlD
Daunorubicin—Dysphagia—Carmustine—brain cancer	0.000135	0.00226	CcSEcCtD
Daunorubicin—Syncope—Procarbazine—brain cancer	0.000135	0.00225	CcSEcCtD
Daunorubicin—Leukopenia—Procarbazine—brain cancer	0.000135	0.00225	CcSEcCtD
Daunorubicin—ABCC10—cerebellum—brain cancer	0.000134	0.0069	CbGeAlD
Daunorubicin—Cardiac failure congestive—Etoposide—brain cancer	0.000133	0.00223	CcSEcCtD
Daunorubicin—Hallucination—Hydroxyurea—brain cancer	0.000133	0.00222	CcSEcCtD
Daunorubicin—Loss of consciousness—Procarbazine—brain cancer	0.000132	0.00221	CcSEcCtD
Daunorubicin—Cough—Procarbazine—brain cancer	0.000131	0.00219	CcSEcCtD
Daunorubicin—Dysphagia—Temozolomide—brain cancer	0.000131	0.00218	CcSEcCtD
Daunorubicin—Convulsion—Procarbazine—brain cancer	0.00013	0.00218	CcSEcCtD
Daunorubicin—Hypertension—Procarbazine—brain cancer	0.00013	0.00217	CcSEcCtD
Daunorubicin—Pancytopenia—Carmustine—brain cancer	0.000128	0.00214	CcSEcCtD
Daunorubicin—Arthralgia—Procarbazine—brain cancer	0.000128	0.00214	CcSEcCtD
Daunorubicin—Myalgia—Procarbazine—brain cancer	0.000128	0.00214	CcSEcCtD
Daunorubicin—Anxiety—Procarbazine—brain cancer	0.000128	0.00213	CcSEcCtD
Daunorubicin—Sweating increased—Temozolomide—brain cancer	0.000127	0.00212	CcSEcCtD
Daunorubicin—Neutropenia—Carmustine—brain cancer	0.000126	0.00211	CcSEcCtD
Daunorubicin—Dry mouth—Procarbazine—brain cancer	0.000125	0.00209	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Etoposide—brain cancer	0.000125	0.00209	CcSEcCtD
Daunorubicin—Pancytopenia—Temozolomide—brain cancer	0.000124	0.00207	CcSEcCtD
Daunorubicin—Cardiac failure—Etoposide—brain cancer	0.000124	0.00207	CcSEcCtD
Daunorubicin—Confusional state—Procarbazine—brain cancer	0.000124	0.00207	CcSEcCtD
Daunorubicin—Vomiting—Lomustine—brain cancer	0.000123	0.00205	CcSEcCtD
Daunorubicin—Oedema—Procarbazine—brain cancer	0.000123	0.00205	CcSEcCtD
Daunorubicin—ABCC2—endocrine gland—brain cancer	0.000122	0.00629	CbGeAlD
Daunorubicin—Dysuria—Temozolomide—brain cancer	0.000122	0.00204	CcSEcCtD
Daunorubicin—Neutropenia—Temozolomide—brain cancer	0.000122	0.00204	CcSEcCtD
Daunorubicin—Infection—Procarbazine—brain cancer	0.000122	0.00204	CcSEcCtD
Daunorubicin—Shock—Procarbazine—brain cancer	0.000121	0.00202	CcSEcCtD
Daunorubicin—Thrombocytopenia—Procarbazine—brain cancer	0.00012	0.00201	CcSEcCtD
Daunorubicin—Depression—Carmustine—brain cancer	0.00012	0.00201	CcSEcCtD
Daunorubicin—Chills—Hydroxyurea—brain cancer	0.00012	0.002	CcSEcCtD
Daunorubicin—Tachycardia—Procarbazine—brain cancer	0.00012	0.002	CcSEcCtD
Daunorubicin—CYP1B1—endocrine gland—brain cancer	0.00012	0.00616	CbGeAlD
Daunorubicin—Hyperhidrosis—Procarbazine—brain cancer	0.000119	0.00198	CcSEcCtD
Daunorubicin—Renal failure—Carmustine—brain cancer	0.000119	0.00198	CcSEcCtD
Daunorubicin—Alopecia—Hydroxyurea—brain cancer	0.000118	0.00197	CcSEcCtD
Daunorubicin—CYP1B1—head—brain cancer	0.000118	0.00608	CbGeAlD
Daunorubicin—Neuropathy peripheral—Carmustine—brain cancer	0.000118	0.00197	CcSEcCtD
Daunorubicin—Stomatitis—Carmustine—brain cancer	0.000118	0.00196	CcSEcCtD
Daunorubicin—Anorexia—Procarbazine—brain cancer	0.000117	0.00195	CcSEcCtD
Daunorubicin—Erythema—Hydroxyurea—brain cancer	0.000117	0.00194	CcSEcCtD
Daunorubicin—Depression—Temozolomide—brain cancer	0.000116	0.00194	CcSEcCtD
Daunorubicin—ABCG2—pituitary gland—brain cancer	0.000115	0.00592	CbGeAlD
Daunorubicin—Cardiac arrest—Etoposide—brain cancer	0.000115	0.00192	CcSEcCtD
Daunorubicin—Nausea—Lomustine—brain cancer	0.000115	0.00192	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Temozolomide—brain cancer	0.000114	0.00191	CcSEcCtD
Daunorubicin—Stomatitis—Temozolomide—brain cancer	0.000114	0.00189	CcSEcCtD
Daunorubicin—TOP2A—Podofilox—Etoposide—brain cancer	0.000112	0.0729	CbGdCrCtD
Daunorubicin—TOP2A—Teniposide—Etoposide—brain cancer	0.000112	0.0729	CbGdCrCtD
Daunorubicin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000112	0.00187	CcSEcCtD
Daunorubicin—Insomnia—Procarbazine—brain cancer	0.000111	0.00185	CcSEcCtD
Daunorubicin—ABCG2—medulla oblongata—brain cancer	0.000111	0.00571	CbGeAlD
Daunorubicin—Sinusitis—Temozolomide—brain cancer	0.000109	0.00182	CcSEcCtD
Daunorubicin—Somnolence—Procarbazine—brain cancer	0.000109	0.00182	CcSEcCtD
Daunorubicin—ABCC10—brain—brain cancer	0.000109	0.0056	CbGeAlD
Daunorubicin—Ill-defined disorder—Hydroxyurea—brain cancer	0.000108	0.0018	CcSEcCtD
Daunorubicin—CYP1B1—central nervous system—brain cancer	0.000108	0.00555	CbGeAlD
Daunorubicin—Anaemia—Hydroxyurea—brain cancer	0.000108	0.0018	CcSEcCtD
Daunorubicin—Hallucination—Carmustine—brain cancer	0.000108	0.0018	CcSEcCtD
Daunorubicin—Decreased appetite—Procarbazine—brain cancer	0.000107	0.00178	CcSEcCtD
Daunorubicin—Fatigue—Procarbazine—brain cancer	0.000106	0.00177	CcSEcCtD
Daunorubicin—CYP1B1—cerebellum—brain cancer	0.000105	0.00542	CbGeAlD
Daunorubicin—Malaise—Hydroxyurea—brain cancer	0.000105	0.00175	CcSEcCtD
Daunorubicin—Pain—Procarbazine—brain cancer	0.000105	0.00175	CcSEcCtD
Daunorubicin—Constipation—Procarbazine—brain cancer	0.000105	0.00175	CcSEcCtD
Daunorubicin—Dysphagia—Etoposide—brain cancer	0.000105	0.00174	CcSEcCtD
Daunorubicin—Leukopenia—Hydroxyurea—brain cancer	0.000104	0.00174	CcSEcCtD
Daunorubicin—Visual impairment—Carmustine—brain cancer	0.000104	0.00174	CcSEcCtD
Daunorubicin—Hallucination—Temozolomide—brain cancer	0.000104	0.00174	CcSEcCtD
Daunorubicin—Sweating increased—Etoposide—brain cancer	0.000102	0.0017	CcSEcCtD
Daunorubicin—ABCG2—midbrain—brain cancer	0.000102	0.00522	CbGeAlD
Daunorubicin—Feeling abnormal—Procarbazine—brain cancer	0.000101	0.00169	CcSEcCtD
Daunorubicin—Convulsion—Hydroxyurea—brain cancer	0.000101	0.00168	CcSEcCtD
Daunorubicin—Visual impairment—Temozolomide—brain cancer	0.000101	0.00168	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Procarbazine—brain cancer	0.000101	0.00168	CcSEcCtD
Daunorubicin—Flushing—Carmustine—brain cancer	0.0001	0.00168	CcSEcCtD
Daunorubicin—Pancytopenia—Etoposide—brain cancer	9.93e-05	0.00166	CcSEcCtD
Daunorubicin—ABCG2—spinal cord—brain cancer	9.91e-05	0.00509	CbGeAlD
Daunorubicin—Discomfort—Hydroxyurea—brain cancer	9.8e-05	0.00164	CcSEcCtD
Daunorubicin—Neutropenia—Etoposide—brain cancer	9.78e-05	0.00163	CcSEcCtD
Daunorubicin—Urticaria—Procarbazine—brain cancer	9.76e-05	0.00163	CcSEcCtD
Daunorubicin—Tinnitus—Temozolomide—brain cancer	9.75e-05	0.00163	CcSEcCtD
Daunorubicin—Body temperature increased—Procarbazine—brain cancer	9.72e-05	0.00162	CcSEcCtD
Daunorubicin—Abdominal pain—Procarbazine—brain cancer	9.72e-05	0.00162	CcSEcCtD
Daunorubicin—Flushing—Temozolomide—brain cancer	9.71e-05	0.00162	CcSEcCtD
Daunorubicin—Cardiac disorder—Temozolomide—brain cancer	9.71e-05	0.00162	CcSEcCtD
Daunorubicin—Arrhythmia—Carmustine—brain cancer	9.67e-05	0.00161	CcSEcCtD
Daunorubicin—Alopecia—Carmustine—brain cancer	9.56e-05	0.0016	CcSEcCtD
Daunorubicin—Oedema—Hydroxyurea—brain cancer	9.51e-05	0.00159	CcSEcCtD
Daunorubicin—ABCC1—cerebellum—brain cancer	9.49e-05	0.00488	CbGeAlD
Daunorubicin—Infection—Hydroxyurea—brain cancer	9.45e-05	0.00158	CcSEcCtD
Daunorubicin—Erythema—Carmustine—brain cancer	9.42e-05	0.00157	CcSEcCtD
Daunorubicin—Chills—Temozolomide—brain cancer	9.38e-05	0.00157	CcSEcCtD
Daunorubicin—Thrombocytopenia—Hydroxyurea—brain cancer	9.31e-05	0.00155	CcSEcCtD
Daunorubicin—Alopecia—Temozolomide—brain cancer	9.24e-05	0.00154	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Etoposide—brain cancer	9.19e-05	0.00153	CcSEcCtD
Daunorubicin—Renal failure—Etoposide—brain cancer	9.16e-05	0.00153	CcSEcCtD
Daunorubicin—Myocardial infarction—Etoposide—brain cancer	9.14e-05	0.00152	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Etoposide—brain cancer	9.14e-05	0.00152	CcSEcCtD
Daunorubicin—Back pain—Carmustine—brain cancer	9.11e-05	0.00152	CcSEcCtD
Daunorubicin—Erythema—Temozolomide—brain cancer	9.1e-05	0.00152	CcSEcCtD
Daunorubicin—Stomatitis—Etoposide—brain cancer	9.09e-05	0.00152	CcSEcCtD
Daunorubicin—Anorexia—Hydroxyurea—brain cancer	9.07e-05	0.00151	CcSEcCtD
Daunorubicin—Hypersensitivity—Procarbazine—brain cancer	9.06e-05	0.00151	CcSEcCtD
Daunorubicin—Dysgeusia—Temozolomide—brain cancer	8.92e-05	0.00149	CcSEcCtD
Daunorubicin—Tremor—Carmustine—brain cancer	8.83e-05	0.00147	CcSEcCtD
Daunorubicin—Asthenia—Procarbazine—brain cancer	8.82e-05	0.00147	CcSEcCtD
Daunorubicin—Back pain—Temozolomide—brain cancer	8.81e-05	0.00147	CcSEcCtD
Daunorubicin—Anaemia—Carmustine—brain cancer	8.71e-05	0.00145	CcSEcCtD
Daunorubicin—Pruritus—Procarbazine—brain cancer	8.7e-05	0.00145	CcSEcCtD
Daunorubicin—Agitation—Carmustine—brain cancer	8.66e-05	0.00144	CcSEcCtD
Daunorubicin—CYP1A2—endocrine gland—brain cancer	8.58e-05	0.00441	CbGeAlD
Daunorubicin—CYP1B1—brain—brain cancer	8.57e-05	0.00441	CbGeAlD
Daunorubicin—Tremor—Temozolomide—brain cancer	8.53e-05	0.00142	CcSEcCtD
Daunorubicin—Dyspnoea—Hydroxyurea—brain cancer	8.48e-05	0.00141	CcSEcCtD
Daunorubicin—CYP1A1—endocrine gland—brain cancer	8.47e-05	0.00435	CbGeAlD
Daunorubicin—Somnolence—Hydroxyurea—brain cancer	8.46e-05	0.00141	CcSEcCtD
Daunorubicin—Ill-defined disorder—Temozolomide—brain cancer	8.45e-05	0.00141	CcSEcCtD
Daunorubicin—Leukopenia—Carmustine—brain cancer	8.43e-05	0.00141	CcSEcCtD
Daunorubicin—Anaemia—Temozolomide—brain cancer	8.42e-05	0.0014	CcSEcCtD
Daunorubicin—Diarrhoea—Procarbazine—brain cancer	8.41e-05	0.0014	CcSEcCtD
Daunorubicin—Agitation—Temozolomide—brain cancer	8.37e-05	0.0014	CcSEcCtD
Daunorubicin—CYP1A1—head—brain cancer	8.36e-05	0.0043	CbGeAlD
Daunorubicin—CYP3A5—endocrine gland—brain cancer	8.28e-05	0.00426	CbGeAlD
Daunorubicin—Decreased appetite—Hydroxyurea—brain cancer	8.27e-05	0.00138	CcSEcCtD
Daunorubicin—Malaise—Temozolomide—brain cancer	8.21e-05	0.00137	CcSEcCtD
Daunorubicin—Fatigue—Hydroxyurea—brain cancer	8.2e-05	0.00137	CcSEcCtD
Daunorubicin—Convulsion—Carmustine—brain cancer	8.16e-05	0.00136	CcSEcCtD
Daunorubicin—Leukopenia—Temozolomide—brain cancer	8.15e-05	0.00136	CcSEcCtD
Daunorubicin—Hypertension—Carmustine—brain cancer	8.13e-05	0.00136	CcSEcCtD
Daunorubicin—Constipation—Hydroxyurea—brain cancer	8.13e-05	0.00136	CcSEcCtD
Daunorubicin—Pain—Hydroxyurea—brain cancer	8.13e-05	0.00136	CcSEcCtD
Daunorubicin—Dizziness—Procarbazine—brain cancer	8.13e-05	0.00136	CcSEcCtD
Daunorubicin—Palpitations—Temozolomide—brain cancer	8.05e-05	0.00134	CcSEcCtD
Daunorubicin—Chest pain—Carmustine—brain cancer	8.02e-05	0.00134	CcSEcCtD
Daunorubicin—Myalgia—Carmustine—brain cancer	8.02e-05	0.00134	CcSEcCtD
Daunorubicin—Anxiety—Carmustine—brain cancer	7.99e-05	0.00133	CcSEcCtD
Daunorubicin—Cough—Temozolomide—brain cancer	7.95e-05	0.00133	CcSEcCtD
Daunorubicin—Convulsion—Temozolomide—brain cancer	7.89e-05	0.00132	CcSEcCtD
Daunorubicin—Hypertension—Temozolomide—brain cancer	7.86e-05	0.00131	CcSEcCtD
Daunorubicin—ABCG2—cerebellum—brain cancer	7.86e-05	0.00404	CbGeAlD
Daunorubicin—Feeling abnormal—Hydroxyurea—brain cancer	7.84e-05	0.00131	CcSEcCtD
Daunorubicin—Vomiting—Procarbazine—brain cancer	7.81e-05	0.0013	CcSEcCtD
Daunorubicin—Flushing—Etoposide—brain cancer	7.77e-05	0.0013	CcSEcCtD
Daunorubicin—Cardiac disorder—Etoposide—brain cancer	7.77e-05	0.0013	CcSEcCtD
Daunorubicin—Confusional state—Carmustine—brain cancer	7.75e-05	0.00129	CcSEcCtD
Daunorubicin—Arthralgia—Temozolomide—brain cancer	7.75e-05	0.00129	CcSEcCtD
Daunorubicin—Myalgia—Temozolomide—brain cancer	7.75e-05	0.00129	CcSEcCtD
Daunorubicin—Rash—Procarbazine—brain cancer	7.75e-05	0.00129	CcSEcCtD
Daunorubicin—Dermatitis—Procarbazine—brain cancer	7.74e-05	0.00129	CcSEcCtD
Daunorubicin—Anxiety—Temozolomide—brain cancer	7.72e-05	0.00129	CcSEcCtD
Daunorubicin—ABCC1—brain—brain cancer	7.71e-05	0.00396	CbGeAlD
Daunorubicin—Headache—Procarbazine—brain cancer	7.7e-05	0.00128	CcSEcCtD
Daunorubicin—Oedema—Carmustine—brain cancer	7.69e-05	0.00128	CcSEcCtD
Daunorubicin—Discomfort—Temozolomide—brain cancer	7.66e-05	0.00128	CcSEcCtD
Daunorubicin—Infection—Carmustine—brain cancer	7.64e-05	0.00127	CcSEcCtD
Daunorubicin—CYP1A1—central nervous system—brain cancer	7.63e-05	0.00392	CbGeAlD
Daunorubicin—Dry mouth—Temozolomide—brain cancer	7.58e-05	0.00126	CcSEcCtD
Daunorubicin—Thrombocytopenia—Carmustine—brain cancer	7.53e-05	0.00126	CcSEcCtD
Daunorubicin—Body temperature increased—Hydroxyurea—brain cancer	7.52e-05	0.00125	CcSEcCtD
Daunorubicin—Chills—Etoposide—brain cancer	7.51e-05	0.00125	CcSEcCtD
Daunorubicin—Tachycardia—Carmustine—brain cancer	7.5e-05	0.00125	CcSEcCtD
Daunorubicin—Confusional state—Temozolomide—brain cancer	7.49e-05	0.00125	CcSEcCtD
Daunorubicin—Oedema—Temozolomide—brain cancer	7.43e-05	0.00124	CcSEcCtD
Daunorubicin—Anaphylactic shock—Temozolomide—brain cancer	7.43e-05	0.00124	CcSEcCtD
Daunorubicin—Alopecia—Etoposide—brain cancer	7.4e-05	0.00123	CcSEcCtD
Daunorubicin—Infection—Temozolomide—brain cancer	7.38e-05	0.00123	CcSEcCtD
Daunorubicin—Anorexia—Carmustine—brain cancer	7.33e-05	0.00122	CcSEcCtD
Daunorubicin—Nausea—Procarbazine—brain cancer	7.3e-05	0.00122	CcSEcCtD
Daunorubicin—Thrombocytopenia—Temozolomide—brain cancer	7.28e-05	0.00121	CcSEcCtD
Daunorubicin—Hyperhidrosis—Temozolomide—brain cancer	7.18e-05	0.0012	CcSEcCtD
Daunorubicin—Dysgeusia—Etoposide—brain cancer	7.13e-05	0.00119	CcSEcCtD
Daunorubicin—Anorexia—Temozolomide—brain cancer	7.08e-05	0.00118	CcSEcCtD
Daunorubicin—Back pain—Etoposide—brain cancer	7.05e-05	0.00118	CcSEcCtD
Daunorubicin—Hypersensitivity—Hydroxyurea—brain cancer	7.01e-05	0.00117	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Carmustine—brain cancer	7.01e-05	0.00117	CcSEcCtD
Daunorubicin—ABCB1—telencephalon—brain cancer	6.97e-05	0.00359	CbGeAlD
Daunorubicin—Insomnia—Carmustine—brain cancer	6.95e-05	0.00116	CcSEcCtD
Daunorubicin—Dyspnoea—Carmustine—brain cancer	6.86e-05	0.00114	CcSEcCtD
Daunorubicin—Somnolence—Carmustine—brain cancer	6.84e-05	0.00114	CcSEcCtD
Daunorubicin—Asthenia—Hydroxyurea—brain cancer	6.82e-05	0.00114	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Temozolomide—brain cancer	6.77e-05	0.00113	CcSEcCtD
Daunorubicin—Ill-defined disorder—Etoposide—brain cancer	6.76e-05	0.00113	CcSEcCtD
Daunorubicin—Anaemia—Etoposide—brain cancer	6.73e-05	0.00112	CcSEcCtD
Daunorubicin—Insomnia—Temozolomide—brain cancer	6.72e-05	0.00112	CcSEcCtD
Daunorubicin—Decreased appetite—Carmustine—brain cancer	6.68e-05	0.00112	CcSEcCtD
Daunorubicin—Dyspnoea—Temozolomide—brain cancer	6.62e-05	0.00111	CcSEcCtD
Daunorubicin—Somnolence—Temozolomide—brain cancer	6.61e-05	0.0011	CcSEcCtD
Daunorubicin—Pain—Carmustine—brain cancer	6.58e-05	0.0011	CcSEcCtD
Daunorubicin—Constipation—Carmustine—brain cancer	6.58e-05	0.0011	CcSEcCtD
Daunorubicin—Malaise—Etoposide—brain cancer	6.57e-05	0.0011	CcSEcCtD
Daunorubicin—Leukopenia—Etoposide—brain cancer	6.52e-05	0.00109	CcSEcCtD
Daunorubicin—Diarrhoea—Hydroxyurea—brain cancer	6.51e-05	0.00109	CcSEcCtD
Daunorubicin—Decreased appetite—Temozolomide—brain cancer	6.46e-05	0.00108	CcSEcCtD
Daunorubicin—Fatigue—Temozolomide—brain cancer	6.41e-05	0.00107	CcSEcCtD
Daunorubicin—Loss of consciousness—Etoposide—brain cancer	6.4e-05	0.00107	CcSEcCtD
Daunorubicin—ABCG2—brain—brain cancer	6.38e-05	0.00328	CbGeAlD
Daunorubicin—Cough—Etoposide—brain cancer	6.36e-05	0.00106	CcSEcCtD
Daunorubicin—Constipation—Temozolomide—brain cancer	6.35e-05	0.00106	CcSEcCtD
Daunorubicin—Pain—Temozolomide—brain cancer	6.35e-05	0.00106	CcSEcCtD
Daunorubicin—Feeling abnormal—Carmustine—brain cancer	6.34e-05	0.00106	CcSEcCtD
Daunorubicin—Convulsion—Etoposide—brain cancer	6.31e-05	0.00105	CcSEcCtD
Daunorubicin—Hypertension—Etoposide—brain cancer	6.29e-05	0.00105	CcSEcCtD
Daunorubicin—Dizziness—Hydroxyurea—brain cancer	6.29e-05	0.00105	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Carmustine—brain cancer	6.29e-05	0.00105	CcSEcCtD
Daunorubicin—CYP3A4—endocrine gland—brain cancer	6.21e-05	0.00319	CbGeAlD
Daunorubicin—Chest pain—Etoposide—brain cancer	6.2e-05	0.00103	CcSEcCtD
Daunorubicin—Discomfort—Etoposide—brain cancer	6.13e-05	0.00102	CcSEcCtD
Daunorubicin—Feeling abnormal—Temozolomide—brain cancer	6.12e-05	0.00102	CcSEcCtD
Daunorubicin—Body temperature increased—Carmustine—brain cancer	6.08e-05	0.00101	CcSEcCtD
Daunorubicin—Abdominal pain—Carmustine—brain cancer	6.08e-05	0.00101	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Temozolomide—brain cancer	6.08e-05	0.00101	CcSEcCtD
Daunorubicin—CYP1A1—brain—brain cancer	6.06e-05	0.00311	CbGeAlD
Daunorubicin—Vomiting—Hydroxyurea—brain cancer	6.05e-05	0.00101	CcSEcCtD
Daunorubicin—Rash—Hydroxyurea—brain cancer	6e-05	0.001	CcSEcCtD
Daunorubicin—Confusional state—Etoposide—brain cancer	6e-05	0.001	CcSEcCtD
Daunorubicin—Dermatitis—Hydroxyurea—brain cancer	5.99e-05	0.001	CcSEcCtD
Daunorubicin—Headache—Hydroxyurea—brain cancer	5.96e-05	0.000994	CcSEcCtD
Daunorubicin—Anaphylactic shock—Etoposide—brain cancer	5.95e-05	0.000992	CcSEcCtD
Daunorubicin—Infection—Etoposide—brain cancer	5.91e-05	0.000985	CcSEcCtD
Daunorubicin—Urticaria—Temozolomide—brain cancer	5.9e-05	0.000985	CcSEcCtD
Daunorubicin—Abdominal pain—Temozolomide—brain cancer	5.87e-05	0.00098	CcSEcCtD
Daunorubicin—Body temperature increased—Temozolomide—brain cancer	5.87e-05	0.00098	CcSEcCtD
Daunorubicin—Thrombocytopenia—Etoposide—brain cancer	5.82e-05	0.000971	CcSEcCtD
Daunorubicin—ABCB1—gonad—brain cancer	5.82e-05	0.00299	CbGeAlD
Daunorubicin—Tachycardia—Etoposide—brain cancer	5.8e-05	0.000968	CcSEcCtD
Daunorubicin—Hyperhidrosis—Etoposide—brain cancer	5.75e-05	0.000959	CcSEcCtD
Daunorubicin—ABCB1—pituitary gland—brain cancer	5.68e-05	0.00292	CbGeAlD
Daunorubicin—Anorexia—Etoposide—brain cancer	5.67e-05	0.000946	CcSEcCtD
Daunorubicin—Hypersensitivity—Carmustine—brain cancer	5.67e-05	0.000945	CcSEcCtD
Daunorubicin—Nausea—Hydroxyurea—brain cancer	5.65e-05	0.000943	CcSEcCtD
Daunorubicin—CYP3A4—central nervous system—brain cancer	5.6e-05	0.00288	CbGeAlD
Daunorubicin—Asthenia—Carmustine—brain cancer	5.52e-05	0.00092	CcSEcCtD
Daunorubicin—ABCB1—medulla oblongata—brain cancer	5.48e-05	0.00282	CbGeAlD
Daunorubicin—Hypersensitivity—Temozolomide—brain cancer	5.47e-05	0.000913	CcSEcCtD
Daunorubicin—Asthenia—Temozolomide—brain cancer	5.33e-05	0.000889	CcSEcCtD
Daunorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	5.31e-05	0.00185	CbGpPWpGaD
Daunorubicin—Dyspnoea—Etoposide—brain cancer	5.3e-05	0.000884	CcSEcCtD
Daunorubicin—Somnolence—Etoposide—brain cancer	5.29e-05	0.000882	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—CDKN2A—brain cancer	5.27e-05	0.00183	CbGpPWpGaD
Daunorubicin—Diarrhoea—Carmustine—brain cancer	5.26e-05	0.000878	CcSEcCtD
Daunorubicin—Pruritus—Temozolomide—brain cancer	5.26e-05	0.000877	CcSEcCtD
Daunorubicin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	5.24e-05	0.00182	CbGpPWpGaD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—TRPC6—brain cancer	5.23e-05	0.00182	CbGpPWpGaD
Daunorubicin—Decreased appetite—Etoposide—brain cancer	5.17e-05	0.000862	CcSEcCtD
Daunorubicin—Fatigue—Etoposide—brain cancer	5.13e-05	0.000855	CcSEcCtD
Daunorubicin—Dizziness—Carmustine—brain cancer	5.08e-05	0.000848	CcSEcCtD
Daunorubicin—Constipation—Etoposide—brain cancer	5.08e-05	0.000848	CcSEcCtD
Daunorubicin—Pain—Etoposide—brain cancer	5.08e-05	0.000848	CcSEcCtD
Daunorubicin—Diarrhoea—Temozolomide—brain cancer	5.08e-05	0.000848	CcSEcCtD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—CCNE1—brain cancer	5.03e-05	0.00175	CbGpPWpGaD
Daunorubicin—ABCB1—midbrain—brain cancer	5.01e-05	0.00257	CbGeAlD
Daunorubicin—XDH—Selenium Micronutrient Network—RELA—brain cancer	4.99e-05	0.00173	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	4.95e-05	0.00172	CbGpPWpGaD
Daunorubicin—CYP3A5—Biological oxidations—CYP2C9—brain cancer	4.92e-05	0.00171	CbGpPWpGaD
Daunorubicin—Dizziness—Temozolomide—brain cancer	4.91e-05	0.00082	CcSEcCtD
Daunorubicin—Feeling abnormal—Etoposide—brain cancer	4.9e-05	0.000817	CcSEcCtD
Daunorubicin—Vomiting—Carmustine—brain cancer	4.89e-05	0.000816	CcSEcCtD
Daunorubicin—ABCB1—spinal cord—brain cancer	4.89e-05	0.00251	CbGeAlD
Daunorubicin—Gastrointestinal pain—Etoposide—brain cancer	4.86e-05	0.000811	CcSEcCtD
Daunorubicin—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	4.85e-05	0.00169	CbGpPWpGaD
Daunorubicin—Rash—Carmustine—brain cancer	4.85e-05	0.000809	CcSEcCtD
Daunorubicin—Dermatitis—Carmustine—brain cancer	4.84e-05	0.000808	CcSEcCtD
Daunorubicin—Headache—Carmustine—brain cancer	4.82e-05	0.000804	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.79e-05	0.00167	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	4.79e-05	0.00167	CbGpPWpGaD
Daunorubicin—Vomiting—Temozolomide—brain cancer	4.72e-05	0.000788	CcSEcCtD
Daunorubicin—Urticaria—Etoposide—brain cancer	4.72e-05	0.000788	CcSEcCtD
Daunorubicin—Body temperature increased—Etoposide—brain cancer	4.7e-05	0.000784	CcSEcCtD
Daunorubicin—Abdominal pain—Etoposide—brain cancer	4.7e-05	0.000784	CcSEcCtD
Daunorubicin—Rash—Temozolomide—brain cancer	4.69e-05	0.000782	CcSEcCtD
Daunorubicin—Dermatitis—Temozolomide—brain cancer	4.68e-05	0.000781	CcSEcCtD
Daunorubicin—Headache—Temozolomide—brain cancer	4.66e-05	0.000777	CcSEcCtD
Daunorubicin—CYP1A1—Biological oxidations—CYP2C9—brain cancer	4.65e-05	0.00162	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—APC—brain cancer	4.64e-05	0.00161	CbGpPWpGaD
Daunorubicin—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	4.58e-05	0.00159	CbGpPWpGaD
Daunorubicin—Nausea—Carmustine—brain cancer	4.57e-05	0.000762	CcSEcCtD
Daunorubicin—CYP3A4—Irinotecan Pathway—APC—brain cancer	4.51e-05	0.00157	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.49e-05	0.00156	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—PCNA—brain cancer	4.46e-05	0.00155	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—HES1—brain cancer	4.45e-05	0.00155	CbGpPWpGaD
Daunorubicin—Nausea—Temozolomide—brain cancer	4.41e-05	0.000736	CcSEcCtD
Daunorubicin—ABCB1—endocrine gland—brain cancer	4.4e-05	0.00226	CbGeAlD
Daunorubicin—Hypersensitivity—Etoposide—brain cancer	4.38e-05	0.000731	CcSEcCtD
Daunorubicin—ABCB1—head—brain cancer	4.34e-05	0.00223	CbGeAlD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	4.34e-05	0.00151	CbGpPWpGaD
Daunorubicin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	4.31e-05	0.0015	CbGpPWpGaD
Daunorubicin—Asthenia—Etoposide—brain cancer	4.27e-05	0.000712	CcSEcCtD
Daunorubicin—Pruritus—Etoposide—brain cancer	4.21e-05	0.000702	CcSEcCtD
Daunorubicin—Diarrhoea—Etoposide—brain cancer	4.07e-05	0.000679	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.04e-05	0.00141	CbGpPWpGaD
Daunorubicin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	4e-05	0.00139	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.99e-05	0.00139	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	3.98e-05	0.00138	CbGpPWpGaD
Daunorubicin—ABCB1—central nervous system—brain cancer	3.96e-05	0.00204	CbGeAlD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.94e-05	0.00137	CbGpPWpGaD
Daunorubicin—Dizziness—Etoposide—brain cancer	3.93e-05	0.000656	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—SKP2—brain cancer	3.93e-05	0.00137	CbGpPWpGaD
Daunorubicin—ABCB1—cerebellum—brain cancer	3.87e-05	0.00199	CbGeAlD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.86e-05	0.00134	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—brain cancer	3.85e-05	0.00134	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.81e-05	0.00133	CbGpPWpGaD
Daunorubicin—Vomiting—Etoposide—brain cancer	3.78e-05	0.000631	CcSEcCtD
Daunorubicin—YWHAG—ErbB1 downstream signaling—STAT3—brain cancer	3.76e-05	0.00131	CbGpPWpGaD
Daunorubicin—Rash—Etoposide—brain cancer	3.75e-05	0.000625	CcSEcCtD
Daunorubicin—Dermatitis—Etoposide—brain cancer	3.75e-05	0.000625	CcSEcCtD
Daunorubicin—Headache—Etoposide—brain cancer	3.73e-05	0.000621	CcSEcCtD
Daunorubicin—TOP2A—Circadian rythm related genes—SIRT1—brain cancer	3.71e-05	0.00129	CbGpPWpGaD
Daunorubicin—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	3.67e-05	0.00128	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.55e-05	0.00123	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	3.54e-05	0.00123	CbGpPWpGaD
Daunorubicin—Nausea—Etoposide—brain cancer	3.53e-05	0.000589	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—SKP2—brain cancer	3.52e-05	0.00122	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDK6—brain cancer	3.5e-05	0.00122	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—CDK4—brain cancer	3.49e-05	0.00121	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	3.48e-05	0.00121	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	3.47e-05	0.00121	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	3.44e-05	0.0012	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.44e-05	0.00119	CbGpPWpGaD
Daunorubicin—YWHAG—ErbB1 downstream signaling—EGFR—brain cancer	3.41e-05	0.00119	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.38e-05	0.00117	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—DNMT1—brain cancer	3.27e-05	0.00114	CbGpPWpGaD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—STAT3—brain cancer	3.27e-05	0.00114	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.16e-05	0.0011	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—CTNNB1—brain cancer	3.16e-05	0.0011	CbGpPWpGaD
Daunorubicin—ABCB1—brain—brain cancer	3.15e-05	0.00162	CbGeAlD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.14e-05	0.00109	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDK6—brain cancer	3.13e-05	0.00109	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.09e-05	0.00108	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.09e-05	0.00108	CbGpPWpGaD
Daunorubicin—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	3.08e-05	0.00107	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	3.06e-05	0.00106	CbGpPWpGaD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—MYC—brain cancer	3.04e-05	0.00106	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	3.03e-05	0.00105	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3e-05	0.00104	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	2.99e-05	0.00104	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—CYP2C9—brain cancer	2.96e-05	0.00103	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—brain cancer	2.95e-05	0.00102	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—ESR2—brain cancer	2.93e-05	0.00102	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—brain cancer	2.93e-05	0.00102	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	2.92e-05	0.00102	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.92e-05	0.00102	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.92e-05	0.00101	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.9e-05	0.00101	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—brain cancer	2.84e-05	0.000986	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—CDK4—brain cancer	2.8e-05	0.000975	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—NOTCH2—brain cancer	2.78e-05	0.000966	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	2.77e-05	0.000961	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.76e-05	0.000961	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—SKP2—brain cancer	2.75e-05	0.000956	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.75e-05	0.000956	CbGpPWpGaD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.74e-05	0.000951	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CCNE1—brain cancer	2.64e-05	0.000918	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—RELA—brain cancer	2.57e-05	0.000893	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—ERBB2—brain cancer	2.55e-05	0.000888	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	2.49e-05	0.000866	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—brain cancer	2.49e-05	0.000865	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—SKP2—brain cancer	2.46e-05	0.000855	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDK6—brain cancer	2.45e-05	0.000852	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—BRCA2—brain cancer	2.44e-05	0.000847	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CYP2C9—brain cancer	2.41e-05	0.000838	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—PDGFRA—brain cancer	2.37e-05	0.000822	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—SIRT1—brain cancer	2.36e-05	0.000822	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CCNE1—brain cancer	2.36e-05	0.00082	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—DTX2—brain cancer	2.36e-05	0.00082	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.34e-05	0.000814	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—PCNA—brain cancer	2.34e-05	0.000813	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—brain cancer	2.33e-05	0.00081	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	2.29e-05	0.000795	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	2.26e-05	0.000784	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—CTNNB1—brain cancer	2.23e-05	0.000777	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDK6—brain cancer	2.19e-05	0.000762	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.19e-05	0.000762	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.13e-05	0.000742	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.12e-05	0.000737	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.12e-05	0.000736	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—TP53—brain cancer	2.1e-05	0.00073	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—PCNA—brain cancer	2.09e-05	0.000727	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—BSG—brain cancer	2.05e-05	0.000712	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDK4—brain cancer	2.02e-05	0.000703	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—MYC—brain cancer	2e-05	0.000694	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	1.97e-05	0.000686	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—VEGFA—brain cancer	1.97e-05	0.000684	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—STAT3—brain cancer	1.95e-05	0.000677	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	1.95e-05	0.000677	CbGpPWpGaD
Daunorubicin—NR5A1—Generic Transcription Pathway—MYC—brain cancer	1.92e-05	0.000668	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	1.9e-05	0.000662	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	1.9e-05	0.000662	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.89e-05	0.000656	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	1.87e-05	0.00065	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.87e-05	0.000649	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CCNE1—brain cancer	1.85e-05	0.000642	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDK4—brain cancer	1.81e-05	0.000628	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.78e-05	0.00062	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP2C9—brain cancer	1.78e-05	0.000618	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—EGFR—brain cancer	1.77e-05	0.000615	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	1.76e-05	0.000613	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—IDH1—brain cancer	1.76e-05	0.000612	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HES5—brain cancer	1.73e-05	0.000602	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—BRCA2—brain cancer	1.7e-05	0.000593	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CCNE1—brain cancer	1.65e-05	0.000574	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.64e-05	0.000572	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	1.64e-05	0.000569	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—PCNA—brain cancer	1.64e-05	0.000569	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.61e-05	0.000559	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	1.59e-05	0.000552	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.59e-05	0.000552	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	1.58e-05	0.000549	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—brain cancer	1.54e-05	0.000537	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.51e-05	0.000526	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—BSG—brain cancer	1.51e-05	0.000525	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.48e-05	0.000514	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	1.48e-05	0.000514	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—PCNA—brain cancer	1.46e-05	0.000508	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDK4—brain cancer	1.41e-05	0.000491	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.4e-05	0.000486	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ENO2—brain cancer	1.39e-05	0.000484	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.38e-05	0.000481	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDKN2A—brain cancer	1.38e-05	0.00048	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	1.35e-05	0.000469	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP2C9—brain cancer	1.33e-05	0.000464	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CCND1—brain cancer	1.31e-05	0.000454	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.3e-05	0.000454	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—IDH1—brain cancer	1.3e-05	0.000452	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	1.3e-05	0.000451	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL2—brain cancer	1.29e-05	0.000449	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP2C9—brain cancer	1.29e-05	0.000449	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	1.27e-05	0.000442	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	1.27e-05	0.00044	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDK4—brain cancer	1.26e-05	0.000439	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.26e-05	0.000437	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.24e-05	0.000432	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	1.24e-05	0.000432	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	1.21e-05	0.000422	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	1.21e-05	0.000422	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—brain cancer	1.19e-05	0.000415	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP2C9—brain cancer	1.17e-05	0.000408	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.17e-05	0.000406	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CCND1—brain cancer	1.17e-05	0.000406	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IDH1—brain cancer	1.17e-05	0.000405	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP2C9—brain cancer	1.16e-05	0.000404	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.14e-05	0.000396	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—BSG—brain cancer	1.13e-05	0.000394	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.11e-05	0.000387	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HEY1—brain cancer	1.1e-05	0.000384	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—BSG—brain cancer	1.1e-05	0.000382	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.1e-05	0.000381	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—DLL1—brain cancer	1.08e-05	0.000377	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—brain cancer	1.08e-05	0.000376	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.06e-05	0.000368	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—MYC—brain cancer	1.05e-05	0.000364	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ENO2—brain cancer	1.03e-05	0.000357	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—BSG—brain cancer	9.98e-06	0.000347	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—BSG—brain cancer	9.88e-06	0.000344	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—IDH1—brain cancer	9.76e-06	0.000339	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDKN2A—brain cancer	9.66e-06	0.000336	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	9.62e-06	0.000334	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—IDH1—brain cancer	9.44e-06	0.000328	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MYC—brain cancer	9.36e-06	0.000325	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—MYC—brain cancer	9.26e-06	0.000322	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ENO2—brain cancer	9.21e-06	0.00032	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SHH—brain cancer	9.21e-06	0.00032	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—brain cancer	9.13e-06	0.000317	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	9.05e-06	0.000315	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—IDH1—brain cancer	8.59e-06	0.000298	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—IDH1—brain cancer	8.5e-06	0.000295	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP2C9—brain cancer	8.41e-06	0.000292	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.32e-06	0.000289	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CCND1—brain cancer	8.16e-06	0.000284	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP2C9—brain cancer	7.95e-06	0.000276	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.94e-06	0.000276	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ENO2—brain cancer	7.71e-06	0.000268	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—brain cancer	7.69e-06	0.000267	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.68e-06	0.000267	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	7.55e-06	0.000263	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ENO2—brain cancer	7.46e-06	0.000259	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MYC—brain cancer	7.32e-06	0.000255	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—BSG—brain cancer	7.15e-06	0.000249	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	7.03e-06	0.000244	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ENO2—brain cancer	6.79e-06	0.000236	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—BSG—brain cancer	6.76e-06	0.000235	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ENO2—brain cancer	6.72e-06	0.000234	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—VAV1—brain cancer	6.65e-06	0.000231	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MYC—brain cancer	6.55e-06	0.000228	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CG—brain cancer	6.39e-06	0.000222	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP2C9—brain cancer	6.35e-06	0.000221	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.21e-06	0.000216	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—IDH1—brain cancer	6.15e-06	0.000214	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.15e-06	0.000214	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—IDH1—brain cancer	5.81e-06	0.000202	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HES1—brain cancer	5.72e-06	0.000199	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PDGFRA—brain cancer	5.45e-06	0.000189	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.41e-06	0.000188	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—BSG—brain cancer	5.4e-06	0.000188	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—brain cancer	5.38e-06	0.000187	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2C9—brain cancer	5.07e-06	0.000176	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.98e-06	0.000173	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.87e-06	0.000169	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ENO2—brain cancer	4.86e-06	0.000169	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IRS2—brain cancer	4.78e-06	0.000166	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.73e-06	0.000165	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CG—brain cancer	4.71e-06	0.000164	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—IDH1—brain cancer	4.64e-06	0.000161	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ENO2—brain cancer	4.59e-06	0.00016	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BSG—brain cancer	4.31e-06	0.00015	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—APC—brain cancer	4.22e-06	0.000147	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.09e-06	0.000142	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2C9—brain cancer	3.91e-06	0.000136	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—IDH1—brain cancer	3.71e-06	0.000129	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ENO2—brain cancer	3.67e-06	0.000128	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CG—brain cancer	3.54e-06	0.000123	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CG—brain cancer	3.42e-06	0.000119	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BSG—brain cancer	3.33e-06	0.000116	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ERBB2—brain cancer	3.28e-06	0.000114	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CG—brain cancer	3.11e-06	0.000108	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CG—brain cancer	3.08e-06	0.000107	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.02e-06	0.000105	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ENO2—brain cancer	2.93e-06	0.000102	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—brain cancer	2.87e-06	9.98e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—IDH1—brain cancer	2.86e-06	9.94e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—brain cancer	2.5e-06	8.7e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—brain cancer	2.32e-06	8.08e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—brain cancer	2.27e-06	7.9e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ENO2—brain cancer	2.26e-06	7.86e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CG—brain cancer	2.23e-06	7.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CG—brain cancer	2.11e-06	7.33e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CG—brain cancer	1.68e-06	5.85e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CG—brain cancer	1.34e-06	4.67e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CG—brain cancer	1.04e-06	3.61e-05	CbGpPWpGaD
